output publications or other works Efficacy and Safety of NRTI¿s Switch to Tenofovir Plus Emtricitabine (Truvada®) vs. Abacavir Plus Lamivudine (Kivexa®) in Patients with Virologic Suppression Receiving a Lamivudine Containing HAART and Never Exposed Tenofovir (TDF) or Abacavir (ABC): A Subanalysis of the BICOMBO Study. Conference Paper